No Detail Found!

Evaluation of miR-625 and miR-302a Expression in Renal Cell Carcinoma

Author(s)
Ali Bazrafshan Golestan University of Medical Sciences,Gorgan,Iran
Zahra Davari Varanlou Golestan University of Medical Sciences,Gorgan,Iran
Alireza Shahryari Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University,Tehran,Iran
Nader Mansour Samaei Department of Medical Genetics, Faculty of Advanced Medical Technologies Golestan University of Medical Sciences,Gorgan,Iran
Mohammad Shafiee Department of Medical Genetics, Faculty of Advanced Medical Technologies Golestan University of Medical Sciences,Gorgan,Iran
Naeme Javid Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences,Gorgan,Iran
Behnaz Bazrafshan Golestan University of Medical Sciences,Gorgan,Iran
Sepideh Siadati Department of Pathology, Faculty of Medicine, Babol University of Medical Science,Babol,Iran
Mohsen Saeidi Golestan University of Medical Sciences,Gorgan,Iran
Abstract
BACKGROUND: Renal cell carcinoma (RCC) is the most common and malignant tumor of kidney tissue, with unknown molecular mechanism and pathogenesis. Recent studies have demonstrated that micro ribonucleic acids (miRNAs) may have potential role in initiation and progression of RCC. In this study we evaluated expression patterns of two RNA molecules, miR-625 and miR-302a in tumor and non-tumor portions of RCC samples.RESULTS: We found approximately 15-fold increase in miR-625 expression in tumor samples compared to non-tumor samples of each patient, but it was not a significant difference (P Value: 0.097). On the other hand, miR-302a expression was similar between tumor and non-tumor sections of the sample (P Value > 0.05). Additionally, we did not find an association between age, gender, grade and stage of tumors, and expression level of either of the two miRNAs. CONCLUSION: Our data demonstrated that there is no significant difference of miR-625 and miR-302a expression in tumor samples of RCC when compared to non-tumor samples. We further found no relationship between clinico-pathological characteristics and expression levels of miR-625 or miR-302a.
Publication Details
Page(s) 60-66
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 8, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
Real-time polymerase chain reaction, miR-625, Human, microRNAs, Gene expression, Carcinoma
References
Lou X,Qi X,Zhang Y,Long H,Yang J .2013 .Decreased expression of microRNA‐625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. J Surg Oncol, 108(4) : 230-5.
White NM,Bao TT,Grigull J,Youssef YM,Girgis A,Diamandis M .2011 .miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol, 186(3) : 1077-83.
Bouyssou JM,Manier S,Huynh D,Issa S,Roccaro AM .1845 .Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta, : 255-265.
George GP,Mittal RD. .2010 .MicroRNAs: Potential biomarkers in cancer. Indian J Clin Biochem, 25 : 4-14.
Hayes J,Peruzzi PP .2014 .and Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med, 20 : 460-9.
Daley GQ .2008 .Common themes of dedifferentiation in somatic cell reprogramming and cancer. Cold Spring Harb Symp Quant Biol, 73 : 171-174.
Huang JJ,Yu J,Li JY,Liu YT,Zhong RQ .2012 .Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Med Oncol, 29 : 2402-8.
Si H,Sun X,Chen Y,Cao Y,Chen S,Wang H .2013 .Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol, 139 : 223-9.
Wang M,Li C,Nie H,Lv X,Qu Y,Yu B .2012 .Downregulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett, 586 : 2382-8.
Wang Z,Qiao Q,Chen M,Li X,Wang Z,Liu C .2014 .-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Lett, 588 : 915-21.
Xu L,Liang YN,Luo XQ,Liu XD,Guo HX .2011 .Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi, 32(3) : 178-81.
Li C,Li DC,Che SS,Ma K,Wang YJ,Xia LH .2015 .The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma. Int J Clin Exp Med, 8 : 9560-4.
Card DA,Hebbar PB,Li L,Trotter KW,Komatsu Y,Mishina Y .2008 .Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol, 28(20) : 6426-38.
Zhang GM,Bao CY,Wan FN,Cao DL,Qin XJ,Zhang HL .2015 .-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer. PLoS One, 10(4) : e0124410.
Lin Zhao,Yan Wang,Yu Lifeng .2016 .cooperatively sensitizes breast cancer cells to adriamycin via suppressing P glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). J Exp Clin Cancer Res, 35 : 25.
Sun S,Zhang G,Wu Z,Shi W,Yang B,Li Y. .2014 .MicroRNA-302a Functions as a Putative Tumor Suppressor in Colon Cancer by Targeting Akt. PLoS One, 9(12) : e115980.
Enver T,Soneji S,Joshi C,Brown J,Iborra F,OrntoftT F .2005 .Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet, 14 : 3129-3140.
Sperger JM,Chen X,Draper JS,Antosiewicz JE,Chon CH,Jones SB .2003 .Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA, 100 : 13350-13355.
He L,Hannon GJ. .2004 .MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5 : 522-31.
Calin GA,Croce CM .2006 .MicroRNA signatures in human cancers. Nat Rev Cancer, 6 : 857-66.
Fang W,Fan Y,Fa Z,Xu J,Yu H,Li P .2017 .microRNA625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma. Oncotarget, 8(8) : 13253.
Li BL,Lu W,Lu C,Qu JJ,Yang TT,Yan Q .2013 .CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer. Cancer Cell Int, 13 : 13-44.
Wei JZ,Tao ML,Han GD,Zhu ZC,Miao ZG .2015 .Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways. Int J Clin Exp Pathol, 8 : 4481-91.
Guo T,Yu W,Lv S,Zhang C,Tian Y .2015 .-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1. Int J Clin Exp Pathol, 8 : 4869-80.
Linehan WM .2012 .Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics. Genome Res, 22(11) : 2089-2100.
0

Citations

0

Downloads

10

Views